homocysteine and Disease Exacerbation

homocysteine has been researched along with Disease Exacerbation in 170 studies

Research

Studies (170)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (3.53)18.2507
2000's78 (45.88)29.6817
2010's76 (44.71)24.3611
2020's10 (5.88)2.80

Authors

AuthorsStudies
Christine, CW; Green, R1
Futschek, IE; Haslacher, H; Lehrner, J; Schernhammer, E; Stögmann, E1
Ghorbani, Z; Martami, F; Razeghi Jahromi, S; Seifishahpar, M; Togha, M1
Chen, X; Chen, Y; Chen, Z; Fan, R; Jiang, Y; Liang, J; Liu, J; Peng, F; Tong, J1
Deng, M; Guo, W; Jiang, Y; Ma, P; Ma, S; Mao, C; Nie, L; Sun, J; Sun, L; Wang, N; Xiong, J; Yang, A; Zhang, H1
Budoff, MJ; Garg, PK; Guan, W; Karger, AB; Nomura, SO; Steffen, BT; Szklo, M; Tsai, MY1
Han, J; Hu, W; Li, X; Yuan, J1
Chen, J; Cui, T; Gao, T; Jian, Z; Li, C; Li, K; Li, S; Liu, L; Ni, Q; Song, P; Tian, Y; Yi, X; Zhang, W; Zhuang, T1
Bosevski, M; Gjorgievski, A; Lazarova, E; Petkoska, D; Stojanovska, L; Zlatanovikj, N1
Li, C; Liu, Y; Tian, T; Wei, B1
Chen, G; Fan, X; Jin, Y; Li, H; Ma, X; Qi, G; Zhang, L1
Bai, Y; Cao, R; Wang, F; Wang, X; Xiao, W; Ye, P1
Kang, MJ; Lee, H; Lee, YB; Park, HM; Park, KH; Shin, DH; Shin, DJ; Sung, YH; Yang, JW1
Farina, N; Hart, K; Jernerén, F; Tabet, N; Turner, C1
Dong, Y; Liu, H; Luo, C; Sun, Q; Wang, H; Wang, W; Wu, Y; Xu, J; Zhang, H; Zhou, Y1
Cui, BB; Fu, RL; Geng, HH; Jin, YP; Li, B; Wang, JJ; Wang, PX; Wang, Q; Zhang, Q1
Bosi, C; Brombo, G; Cervellati, C; Morieri, ML; Passaro, A; Trentini, A; Valacchi, G; Zuliani, G; Zurlo, A1
Li, L; Liu, J; Wang, H; Zhao, H; Zhao, XX; Zhou, Y1
Cui, C; Fernandez-Escobar, A; Jin, M; Liu, Z; Mao, J; Wang, K; Wang, X; Wu, Q; Xu, K1
Apeland, T; Jonsson, G; Mansoor, MA; Marti, HP; Slettan, A; Tariq, A; Weeraman, P1
Chen, J; Cui, X; Ding, X; Fang, Y; Kuang, Q; Shen, Z; Xue, N1
Alfieri, DF; de Almeida, ERD; Dichi, I; Flauzino, T; Kaimen-Maciel, DR; Kallaur, AP; Lozovoy, MAB; Morimoto, HK; Oliveira, SR; Reiche, EMV; Sabino, BS; Simão, ANC1
Brodacki, B; Piusińska-Macoch, R; Skrobowska, E; Staszewski, J; Stępień, A1
Bhadelia, RA; Folstein, MF; Qiu, WQ; Rosenberg, IH; Scott, TM1
Alarcón, GS; Alfaro-Lozano, JL; Cucho-Venegas, JM; Elera-Fitzcarrald, C; Gamboa-Cárdenas, RV; Iparraguirre-López, H; Medina-Chinchon, M; Pastor-Asurza, CA; Perich-Campos, RA; Pimentel-Quiroz, VR; Reátegui-Sokolova, C; Rodríguez-Bellido, ZJ; Sarmiento-Velasquez, O; Ugarte-Gil, MF; Zeña-Huancas, PA; Zevallos-Miranda, F1
Allan, AM; Brigman, J; Jacobsen, DW; Jindal, A; Miller, JW; Paul, S; Poddar, R; Rajagopal, S; Winter, L1
Burn, DJ; Duncan, GW; Johnston, F; Khoo, TK; Lawson, RA; Sleeman, I; Yarnall, AJ1
Aksamit, D; Drozdz, M; Ignacak, E; Janda, K; Kowalczyk-Michałek, M; Krzanowski, M; Sułowicz, W; Tabor-Ciepiela, B1
Ahmadi, N; Budoff, M; Ebrahimi, R; Flores, F; Hajsadeghi, F; Nabavi, V; Zeb, I1
Bertini, E; Boenzi, S; Di Giovamberardino, G; Dionisi-Vici, C; Martinelli, D; Pastore, A; Petrillo, S; Piemonte, F; Tozzi, G1
Chang, AY; Chang, CC; Chang, WN; Chang, YT; Chen, NC; Huang, CW; Huang, SH; Lee, CC; Lui, CC1
Ahluwalia, N; Blacher, J; Faure, P; Galan, P; Hercberg, S; Julia, C; Szabo de Edelenyi, F1
Bulum, T; Duvnjak, L1
Han, SJ; Jang, HS; Jung, KJ; Kim, JI; Park, JW; Park, KM1
Andras, A; Hansrani, M; Stansby, G1
Digumarti, RR; Divyya, S; Gottumukkala, SR; Kotamraju, S; Kumaraswami, K; Kutala, VK; Naushad, SM; Reddy, CA1
Li, H; Li, J; Lu, Z; Men, X; Zhang, B; Zhang, L1
Charles-Schoeman, C; Fitzgerald, J; Gorn, A; Grossman, JM; Hahn, BH; Karpouzas, GA; Lourenco, EV; McMahon, M; Ragavendra, N; Sahakian, L; Skaggs, BJ; Taylor, MB; Wallace, DJ; Watson, KE; Weisman, MH; Wong, WK1
Geerlings, MI; Kloppenborg, RP; Mali, WP; Nederkoorn, PJ; van der Graaf, Y; Vermeulen, M; Visseren, FL1
Li, J; Shi, M; Xie, M; Yan, L; Zhang, H1
Basu, A; Garvey, WT; Jenkins, AJ; Klein, RL; Lopes-Virella, MF; Lyons, TJ; Stoner, JA; Thorpe, SR1
Callà, C; De Stefano, A; Dessì, M; Di Daniele, N; Di Giovamberardino, G; Noce, A; Pastore, A; Zenobi, R1
Cohen, E; Garty, M; Goldberg, E; Krause, I; Levi, A; Levi, M1
Aliani, M; House, JD; Mayengbam, S; Raposo, S1
Hlushchenko, SV; Zviagintseva, TD1
Catena, C; Colussi, G; Nait, F; Sechi, LA; Url-Michitsch, M1
Fernández Castillo, R; Fernández Gallegos, R; Gomez Jimenez, FJ; Quero Alfonso, AI1
Asghari, A; Eidi, A; Mohammadian, Z; Mortazavi, P; Tavangar, MM1
Bang, H; Spence, JD; Urquhart, BL1
Ge, SJ; Guan, ZH; Hu, MY; Zhang, HL; Zhang, T; Zheng, LQ1
Ansari, Z1
Duan, S; Li, L; Ren, C; Xie, J; Zhang, S1
Cui, Y; Kong, X; Wei, W; Wei, Y; Zhang, J; Zheng, L1
Fendler, W; Lukamowicz, J; Miklaszewska, M; Tkaczyk, M1
Amin, HK; El-Sayed, MI; Leheta, OF1
Hou, FF; Huo, Y; Li, Y; Liang, M; Qin, X; Sun, D; Wang, B; Wang, J; Xu, X1
Bickel, C; Blankenberg, S; Lackner, K; Lubos, E; Proust, C; Rupprecht, H; Schnabel, RB; Sinning, C; Tregouet, D; Westermann, D; Zengin, E1
Bala, J; Behera, J; Nuru, M; Tyagi, N; Tyagi, SC1
Oláh, E; V Oláh, A; Varga, P1
Loftus, I; Thompson, M1
Blom, HJ; Dijkstra, CD; Killestein, J; Kragt, JJ; Polman, CH; Teunissen, CE1
Kristofova, B; Valocik, G; Valocikova, I1
Dagenais, G; Held, C; Lonn, E; McQueen, M; Sheridan, P; Smith, S; Sumner, G; Yusuf, S1
Aliabadi, P; Fayfman, M; Felson, DT; Hunter, DJ; Niu, J; Sack, B; Selhub, J; Zhang, YQ1
Alaupovic, P; Azen, SP; Detrano, R; Dustin, L; Hodis, HN; Hwang, J; Liu, CH; Liu, CR; Mack, WJ; Mahrer, PR; Selhub, J; Selzer, RH; Wilcox, AG1
Ochudło, S; Opala, G; Siuda, J; Targosz-Gajniak, M1
Aksungar, FB; Bektaş, O; Levent, E; Sariman, N; Soylu, AC1
Akgül, E; Kaya, C; Pabuccu, R1
Avilés, F; Burgos, MI; Fenollar, M; Parra, MS1
Croxford, R; Depeint, F; Kim, YI; Lindzon, GM; Medline, A; Sohn, KJ1
Annerbo, S; Kivipelto, M; Lokk, J1
Boehm, BO; Fuchs, D; Grammer, TB; März, W; Schroecksnadel, K1
Amato, A; Cini, M; Conti, E; Favaretto, E; Legnani, C; Palareti, G; Sartori, M1
Chung, WS; Ihm, SH; Kim, DB; Kim, HY; Kim, JH; Lee, JM; Park, CS; Seung, KB; Yoo, KD1
Handels, R; van Rossum, IA; Visser, PJ; Vos, S1
Bleie, O; Blix, AJ; Ebbing, M; Løland, KH; Nordrehaug, JE; Nygård, O; Refsum, H; Strand, E; Ueland, PM1
Ansquer, JC; Brugère, L; Foucher, C1
Albanese, A; Bowlus, CL; Devaraj, S; French, SW; Gregory, JF; Halsted, CH; Medici, V; Panacek, EA; Peerson, JM; Rahim, N; Richards, JR; Rossaro, L; Stabler, SP; Virata, MC1
Rabbani, N; Thornalley, PJ1
Collin, SM; Cox, A; Davis, M; Donovan, JL; Hamdy, FC; Johnston, C; Lane, JA; Lewis, SJ; Marsden, G; Martin, RM; Metcalfe, C; Neal, DE; Refsum, H; Smith, AD; Smith, GD1
Bathgate, D; Chinnery, PF; Fowler, B; Taylor, RW; Webb, B; Yu-Wai-Man, P1
Bots, ML; Durga, J; Grobbee, DE; Kok, FJ; Schouten, EG; Verhoef, P1
Liu, WH; Liu, WJ; Ma, LQ; Zhang, KQ; Zhou, W; Zou, CG1
Müller, T1
Firbank, MJ; Ford, GA; Hansrani, M; Narayan, SK; O'Brien, JT; Saxby, BK; Stansby, G1
Hirayama, A; Nagao, K; Nomoto, K; Tani, S; Washio, T; Watanabe, I1
Ambrožič, A; Cikeš, N; Cučnik, S; Hojs, R; Holc, I; Kveder, T; Pahor, A; Rozman, B1
Chai, HT; Chang, LT; Chen, HC; Chen, YL; Chung, SY; Fan, CQ; Sun, CK; Sung, PH; Tsai, TH; Yang, CH; Yip, HK1
Gao, C; Gao, Y; Li, X; Wei, S; Zhang, M; Zhong, L1
Carducci, MA; Herman, JG; Shabbeer, S; Simons, BW; Williams, SA1
Huo, Y; Li, J; Qin, X; Wang, X; Xu, M; Xu, X; Zhang, Y1
Durajski, L; Fijorek, K; Głowacki, R; Kozynacka, A; Mazur, P; Pfitzner, R; Sadowski, J; Undas, A1
Demidova, VS; Doguzhieva, RM; Lebedeva, AN; Pokrovskiĭ, AV1
Chłopicki, S; Franczyk-Żarów, M; Gajda, M; Jackson, CL; Kostogrys, RB; Maślak, E; Mateuszuk, L1
de Groot, LC; Geerlings, MI; Jochemsen, HM; Kampman, E; Kloppenborg, RP; Mali, WP; van der Graaf, Y1
Ascaso, JF; Chaves, FJ; Folgado, J; Gonzalez, R; Lorente, R; Martínez-Hervás, S; Molina, M; Priego, A; Real, JT1
Hansrani, M; Stansby, G1
Grzeszczak, W; Gumprecht, J; Zukowska-Szczechowska, E; Zychma, MJ1
Ambrose, JA; Bilianou, HI; DeVoe, MC; Fakiolas, CN; Foussas, SG; Manousakis, SJ; Olympios, CD; Papadaki, OA; Pissimissis, EG; Stefanidis, AS; Zairis, MN1
Beck, GJ; Greene, T; Kusek, JW; Levey, AS; Sarnak, MJ; Selhub, J; Wang, SR1
Frick, B; Fuchs, D; Schröcksnadel, K1
Bleich, S; Falkai, P; Kessler, H; Supprian, T1
Chmiel, G; Drozdz, M; Klimeczek, P; Konieczyńska, M; Kowalczyk-Michałek, M; Kraśniak, A; Pasowicz, M; Podolec, P; Sułowicz, W; Szumilak, D; Tracz, W; Wicher-Muniak, E1
Griffin, BP; Novaro, GM1
Chodakowska-Zebrowska, M; Pniewski, J; Stafiej, A; Stepień, K; Woźniak, R1
Taylor, LM1
Aranda, JL; Díaz-Rubio, P; Fernández-Miranda, C; Gómez de la Cámara, A; Gómez, P; Martínez, J; Núñez, V; Paz, M1
Agelink, MW; Andrich, J; Arz, A; Kraus, PH; Kuhn, W; Müller, T; Saft, C; Schneider, B1
Frick, MH; Humphries, SE; Kesäniemi, YA; Nieminen, MS; Pasternack, A; Syvänne, M; Taskinen, MR; Turpeinen, U; Whittall, RA1
Arai, H; Maruyama, M; Matsui, T; Nemoto, M; Ootsuki, M; Sasaki, H; Tanji, H; Tomita, N1
Kowalska, I; Lewczuk, A; Mroczko, B; Musiał, W; Prokop, J; Sawicki, R; Skibińska, E1
Alberola, V; Almenar, D; Artal, A; Barcelo, R; Bover, I; Camps, C; Cobo, M; de las Peñas, R; Diz, P; Garcia-Gomez, R; Gonzalez-Larria, JL; Insa, A; Isla, D; Massuti, B; Muñoz, MA; Rosell, R; Sanchez, JJ; Sanchez-Ronco, M; Sarries, C; Taron, M; Terrasa, J1
Gustafson, L; Hultberg, B; Nilsson, K1
Davies, G; Duguid, J; Gray, R; Hill, D; Hudson, P; McCaddon, A; Tandy, S1
Lang, AE; Postuma, RB1
Harringer, W; Haverich, A; Kutschka, I; Pethig, K; Strüber, M1
Aggarwal, SP; Narang, AP; Sandhu, JS; Sandhu, P; Singh, I1
Giusti, B; Lapini, I; Lenti, M; Marcucci, R; Pepe, G; Sestini, I; Yacoub, M1
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR1
Boxer, AL; Finley, R; Goldman, J; Johnston, K; Kramer, JH; Miller, BL1
Allen, RH; Brown, TR; DeCarli, C; Paik, MC; Sacco, RL; Stabler, SP; Wright, CB1
Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C1
Bukia, T; Chaava, M; Gogokhia, N1
Aziz, DC; Blumenthal, RS; Budoff, MJ; Nasir, K; Park, R; Rasouli, ML1
Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE1
Malberti, F; Mallamaci, F; Ravani, P; Testa, S; Tripepi, G; Zoccali, C1
Fowler, B1
Branzi, A; Carigi, S; Coccolo, F; Grigioni, F; Kessels, K; Koessels, K; Magelli, C; Magnani, G; Marrozzini, C; Marzocchi, A; Musuraca, AC; Ortolani, P; Potena, L; Russo, A; Sassi, S1
Zoccali, C1
Hu, R; Lau, CP; Tse, HF; Wang, WQ; Zhang, XX1
Bartis, C; Bottiglieri, T; Dewey, RB; Diaz-Arrastia, R; O'Suilleabhain, PE; Oberle, R1
Belaia, OL; Fedorova, NV1
Kelemen, LE1
Guthikonda, S; Haynes, WG1
Beale, P; Clarke, SJ; Horvath, L; Ong, S; Rivory, L; Sharma, R1
Bertoletti, E; Chilovi, BV; Conti, M; Del Rio, I; Padovani, A; Rozzini, L; Trabucchi, M1
Dichgans, M; Gschwendtner, A; Herzog, J; Holtmannspötter, M; Opherk, C; Peters, N; Sämann, P1
Aboyans, V; Criqui, MH; Denenberg, JO; Fronek, A; Knoke, JD; Ridker, PM1
Chernikova, IV; Kostiuchenko, GI; Kostiuchenko, LA; Kulikov, VP1
Taute, BM1
Böger, CA; Christ, J; Götz, AK; Haak, T; Hoffmann, U; Krämer, BK; Riegger, GA; Stubanus, M1
Hasegawa, Y; Jiang, Y; Qin, J; Song, J; Sun, F; Wu, X; Yamaguchi, S; Yang, Y; Zhang, Y1
Leonova, SF; Shirokov, EA1
Archetti, S; Borroni, B; Cesana, BM; Ferrari, M; Padovani, A1
Beck, J; Hinderliter, A; Offenbacher, S; Ohman, EM; Oppenheimer, SM; Sen, PK; Sen, S; Simmons, J1
Degtereva, OA; Menshutina, MA; Panina, IIu; Petrishchev, NN; Rumiantsev, ASh; Smirnov, AV; Tugusheva, FA1
Bitetto, D; Cussigh, A; De Feo, T; Fabris, C; Falleti, E; Fontanini, E; Fornasiere, E; Marangoni, F; Minisini, R; Pirisi, M; Toniutto, P1
Crow, MK; Davis, A; Devereux, RB; Levine, DM; Lockshin, MD; Paget, SA; Roman, MJ; Salmon, JE; Sammaritano, L1
Aguglia, U; Battaglia, L; Condino, F; de Marco, V; Luise, F; Morabito, F; Morabito, P; Piromalli, A; Quattrone, A; Russo, C; Trapani Lombardo, V; Vinci, A1
Campolo, J; Caruso, R; Cighetti, G; De Maria, R; Frigerio, M; Oliva, F; Parodi, O; Parolini, M; Roubina, E; Vitali, E1
Cakal, E; Goksu, M; Ozkaya, M; Yuzbasioglu, MF1
Nehler, MR; Porter, JM; Taylor, LM1
Dennis, VW; Robinson, K1
Clarke, R; Jobst, KA; Refsum, H; Smith, AD; Sutton, L; Ueland, PM1
Moneta, GL; Porter, JM; Schuff, RA; Sexton, GJ; Taylor, LM1
Alaupovic, P; Attman, PO; Knight-Gibson, C; Larsson, R; Lee, DM; Mulec, H; Mullen, JK; Samuelsson, O; Weiss, L1
Clagett, GP; Jackson, MR; McIntyre, KE; Modrall, JG; Valentine, RJ1
Hackam, DG; Peterson, JC; Spence, JD1
Barnetson, L; Budge, M; Bungay, H; Clarke, R; Esiri, M; Frost, C; Joachim, C; King, E; Molyneux, A; Morris, J; Smith, AD1
Hayakawa, T; Kamiya, H; Kondo, J; Kosokabe, T; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Suzuki, T; Tomida, T; Tsuboi, H1
Brzósko, S; Hryszko, T; Małyszko, J; Myśliwiec, M1
Beaudeux, JL; Bruckert, E; Foglietti, MJ; Giral, P; Jacob, N1
Debreceni, L1
Brown, AT; Delongchamp, RR; Fink, LM; Fonseca, VA; Poirier, LA; Randolph, CJ; Wise, CK1
Graf, S; Hornykewycz, S; Huber, K; Huber-Beckmann, R; Nikfardjam, M; Wojta, J; Zorn, G1
Emeis, JJ; Hovind, P; Parving, HH; Rossing, P; Stehouwer, CD; Tarnow, L; Teerlink, T1
Almadori, G; Bussu, F; Cadoni, G; Galli, J; Giardina, B; Minucci, A; Persichilli, S; Zappacosta, B1
Cohen, B; Lima, J; Oppenheimer, SM; Sen, S1
Dambinova, SA; Khounteev, GA; Skoromets, AA1

Reviews

28 review(s) available for homocysteine and Disease Exacerbation

ArticleYear
Serum levels of Homocysteine, Vitamin B12 and Folate in Patients with Multiple Sclerosis: an Updated Meta-Analysis.
    International journal of medical sciences, 2020, Volume: 17, Issue:6

    Topics: Adult; Case-Control Studies; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multiple Sclerosis; Vitamin B 12

2020
Role of homocysteine in the development and progression of Parkinson's disease.
    Annals of clinical and translational neurology, 2020, Volume: 7, Issue:11

    Topics: Disease Progression; Homocysteine; Humans; Parkinson Disease

2020
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    The Cochrane database of systematic reviews, 2013, Jul-19, Issue:7

    Topics: Arteriosclerosis; Disease Progression; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Tetrahydrofolates; Vascular Grafting; Vitamin B Complex

2013
Elevated serum homocysteine level in the development of diabetic peripheral neuropathy.
    Genetics and molecular research : GMR, 2015, Nov-30, Volume: 14, Issue:4

    Topics: Aged; Asian People; Biomarkers; Case-Control Studies; China; Diabetes Mellitus; Diabetic Neuropathies; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Risk Factors; White People

2015
Homocysteine and Mild Cognitive Impairment: Are These the Tools for Early Intervention in the Dementia Spectrum?
    The journal of nutrition, health & aging, 2016, Volume: 20, Issue:2

    Topics: Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B Complex

2016
Homocysteine as a Pathological Biomarker for Bone Disease.
    Journal of cellular physiology, 2017, Volume: 232, Issue:10

    Topics: Animals; Biomarkers; Bone and Bones; Bone Remodeling; Chondrocytes; Collagen; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Matrix Metalloproteinases; Mitochondria; Osteoclasts; Osteogenesis; Osteoporosis; Oxidative Stress; Regional Blood Flow

2017
[Biochemical alterations in patients with Down syndrome].
    Orvosi hetilap, 2008, Jun-29, Volume: 149, Issue:26

    Topics: Acetylglucosaminidase; Adult; Alzheimer Disease; Antioxidants; Bilirubin; Blood Proteins; Cystathionine beta-Synthase; Disease Progression; Down Syndrome; Ferritins; Folic Acid; Homocysteine; Humans; Learning; Nootropic Agents; Quality of Life; S100 Proteins; Serum Albumin; Superoxide Dismutase; Transferrin; Vitamin B 12

2008
Plaque biology: interesting science or pharmacological treasure trove?
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2008, Volume: 36, Issue:5

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Atherosclerosis; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Agents; Cytokines; Disease Progression; Hematologic Agents; Homocysteine; Humans; Hypolipidemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Lipid Metabolism; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Protease Inhibitors; Signal Transduction

2008
Cardiac biomarkers and chronic renal diseases.
    Bratislavske lekarske listy, 2008, Volume: 109, Issue:8

    Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin

2008
Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design.
    Journal of Alzheimer's disease : JAD, 2010, Volume: 20, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Clinical Trials as Topic; Cognition Disorders; Disease Progression; Homocysteine; Humans; Lipid Metabolism; Peptide Fragments; tau Proteins

2010
Fenofibrate, homocysteine and renal function.
    Current vascular pharmacology, 2010, Volume: 8, Issue:5

    Topics: Animals; Biomarkers; Creatinine; Disease Progression; Dyslipidemias; Fenofibrate; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Kidney; PPAR alpha; Renal Insufficiency; Risk Factors; Sulfhydryl Compounds

2010
Motor complications, levodopa metabolism and progression of Parkinson's disease.
    Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:7

    Topics: Animals; Arteriosclerosis; Catechol O-Methyltransferase; Disease Progression; Dopamine; Dyskinesias; Enzyme Inhibitors; Free Radicals; Homocysteine; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Synaptic Transmission

2011
Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Atherosclerosis, 2012, Volume: 222, Issue:2

    Topics: Adult; Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Disease Progression; Evidence-Based Medicine; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B Complex

2012
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    The Cochrane database of systematic reviews, 2002, Issue:3

    Topics: Arteriosclerosis; Disease Progression; Homocysteine; Humans; Peripheral Vascular Diseases

2002
[Homocysteine and dementia].
    Fortschritte der Neurologie-Psychiatrie, 2003, Volume: 71, Issue:3

    Topics: Alzheimer Disease; Biomarkers; Cerebral Amyloid Angiopathy; Dementia; Dementia, Vascular; Disease Progression; Homocysteine; Humans; Risk Factors

2003
Calcific aortic stenosis: another face of atherosclerosis?
    Cleveland Clinic journal of medicine, 2003, Volume: 70, Issue:5

    Topics: Aortic Valve Stenosis; Calcinosis; Disease Progression; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Risk Factors

2003
Elevated plasma homocysteine as risk factor for peripheral arterial disease--what is the evidence?
    Seminars in vascular surgery, 2003, Volume: 16, Issue:3

    Topics: Arteriosclerosis; Disease Progression; Evidence-Based Medicine; Homocysteine; Humans; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Risk Factors

2003
Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
    Neurology, 2004, Sep-14, Volume: 63, Issue:5

    Topics: Antiparkinson Agents; Arteriosclerosis; Catechol O-Methyltransferase; Dementia; Disease Progression; Disease Susceptibility; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Levodopa; Models, Biological; Multicenter Studies as Topic; Oxidative Stress; Parkinson Disease; Randomized Controlled Trials as Topic; Substantia Nigra

2004
Role of hyperhomocysteinemia in aortic disease.
    Cellular and molecular biology (Noisy-le-Grand, France), 2004, Volume: 50, Issue:8

    Topics: Aged; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Diseases; Collagen; Disease Progression; Extracellular Matrix; Female; Fibrillin-1; Fibrillins; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Marfan Syndrome; Microfilament Proteins; Middle Aged; Risk; Thrombosis; Vascular Diseases

2004
Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.
    Seminars in vascular medicine, 2005, Volume: 5, Issue:2

    Topics: Animals; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Oxidation-Reduction

2005
Biomarkers in chronic kidney disease: utility and issues towards better understanding.
    Current opinion in nephrology and hypertension, 2005, Volume: 14, Issue:6

    Topics: Animals; Arginine; Biomarkers; C-Reactive Protein; Chronic Disease; Disease Progression; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Troponin T

2005
The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?
    International journal of cancer, 2006, Jul-15, Volume: 119, Issue:2

    Topics: Animals; Canada; Carrier Proteins; Cytosol; Dietary Supplements; Disease Progression; DNA, Neoplasm; Folate Receptor 1; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Homocysteine; Humans; Mutation; Neoplasms; Prognosis; Receptors, Cell Surface; Transcription Factors; Tumor Cells, Cultured; United States

2006
Homocysteine: role and implications in atherosclerosis.
    Current atherosclerosis reports, 2006, Volume: 8, Issue:2

    Topics: Atherosclerosis; Biomarkers; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Risk Factors

2006
Homocysteinemia as a risk factor for atherosclerosis: a review.
    Cardiovascular surgery (London, England), 1997, Volume: 5, Issue:6

    Topics: Arteriosclerosis; Coronary Artery Disease; Disease Progression; Homocysteine; Humans; Hypertension; Risk Factors

1997
[Homocysteine--new risk factor for progression of atherosclerosis and its complications].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2001, Volume: 10, Issue:55

    Topics: Arteriosclerosis; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors

2001
[New non-lipidic biological markers of atherosclerosis].
    Annales de medecine interne, 2001, Volume: 152, Issue:3

    Topics: Arteriosclerosis; Biomarkers; Blood Coagulation Factors; Cell Adhesion Molecules; Chemokines; Cytokines; Disease Progression; Endothelium, Vascular; Fibrinolysis; Foam Cells; Homocysteine; Humans; Inflammation; Monocytes; Reproducibility of Results; Risk Factors; Sensitivity and Specificity

2001
[Homocysteine--a risk factor for atherosclerosis].
    Orvosi hetilap, 2001, Jul-08, Volume: 142, Issue:27

    Topics: Antioxidants; Arteriosclerosis; Disease Progression; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Risk Factors; Thrombosis; Treatment Outcome; Vitamin B 12; Vitamin B 6

2001
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2002, Volume: 13, Issue:2

    Topics: Biomarkers; Brain; Disease Progression; Double-Blind Method; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamins

2002

Trials

24 trial(s) available for homocysteine and Disease Exacerbation

ArticleYear
Nitration-mediated deficiency of cystathionine β-synthase activity accelerates the progression of hyperhomocysteinemia.
    Free radical biology & medicine, 2017, Volume: 113

    Topics: Adult; Aged; Aged, 80 and over; Animals; Cystathionine beta-Synthase; Disease Models, Animal; Disease Progression; Female; Free Radical Scavengers; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metalloporphyrins; Middle Aged; Mutation; Nitro Compounds; Nitrosative Stress; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tyrosine

2017
The effect of cardiovascular risk factors on the carotid intima-media thickness in an old-aged cohort with hypertension: a longitudinal evolution with 4-year follow-up of a random clinical trial.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2019, Volume: 41, Issue:1

    Topics: Aged; Atherosclerosis; Blood Pressure; C-Reactive Protein; Carotid Intima-Media Thickness; Cholesterol; Disease Progression; Female; Heart Rate; Homocysteine; Humans; Hypertension; Life Style; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Risk Factors; Waist Circumference

2019
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis.
    International journal of cardiology, 2013, Oct-03, Volume: 168, Issue:3

    Topics: Adipose Tissue, Brown; Adipose Tissue, White; Adult; Aged; Atherosclerosis; Coronary Artery Disease; Coronary Vessels; Dietary Supplements; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Garlic; Homocysteine; Humans; Male; Middle Aged; Pericardium; Plant Extracts; Risk Factors; Thermometry; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2013
Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Atherosclerosis, 2013, Volume: 228, Issue:2

    Topics: Aged; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Disease Progression; Double-Blind Method; Female; France; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors

2013
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
    JAMA internal medicine, 2016, Oct-01, Volume: 176, Issue:10

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; China; Disease Progression; Double-Blind Method; Drug Combinations; Enalapril; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Vitamin B Complex

2016
Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
    Vascular medicine (London, England), 2008, Volume: 13, Issue:4

    Topics: Aged; Biomarkers; Calcinosis; Canada; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Artery, Common; Disease Progression; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2008
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial.
    Stroke, 2009, Volume: 40, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Atherosclerosis; Calcium; Carotid Arteries; Coronary Vessels; Dietary Supplements; Disease Progression; Double-Blind Method; Echocardiography; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Patient Compliance; Treatment Outcome; Vitamin B Complex

2009
Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
    The American journal of cardiology, 2010, Jun-01, Volume: 105, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Norway; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2010
Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults.
    The American journal of clinical nutrition, 2011, Volume: 93, Issue:5

    Topics: Aged; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Dietary Supplements; Disease Progression; Double-Blind Method; Elasticity; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Netherlands; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography

2011
Elevated plasma homocysteine is associated with increased brain atrophy rates in older subjects with mild hypertension.
    Dementia and geriatric cognitive disorders, 2011, Volume: 31, Issue:5

    Topics: Aged; Aged, 80 and over; Anatomy, Cross-Sectional; Atrophy; Brain; Cerebral Infarction; Disease Progression; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hypertension; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Prognosis; Regression Analysis; Riboflavin; Risk Factors

2011
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cysteine; Diet, Protein-Restricted; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Prognosis; Pyridoxal Phosphate; Risk Factors; Vitamin B 12

2002
[Evaluation of atherosclerosis progression in patients treated repeatedly with hemodialysis].
    Przeglad lekarski, 2002, Volume: 59, Issue:8

    Topics: Adult; Aged; Arteries; Arteriosclerosis; Calcium; Cholesterol, LDL; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Ultrasonography

2002
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
    Atherosclerosis, 2004, Volume: 172, Issue:2

    Topics: Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Gemfibrozil; Homocysteine; Humans; Hypolipidemic Agents; Male; Methylenetetrahydrofolate Reductase (NADPH2); Triglycerides

2004
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
    Clinical lung cancer, 2004, Volume: 5, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; DNA Methylation; Female; Gemcitabine; Genes, Tumor Suppressor; Genotype; Homocysteine; Humans; Lung Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome

2004
Absence of macrocytic anaemia in Alzheimer's disease.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anemia, Macrocytic; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Platelet Count; Sex Factors; Vitamin B 12

2004
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:3

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome

2005
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:9

    Topics: Adult; Cytomegalovirus Infections; Disease Progression; Female; Folic Acid; Heart Diseases; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Hyperplasia; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrahydrofolates; Time Factors; Ultrasonography; Vascular Diseases

2005
A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.
    British journal of cancer, 2006, Apr-10, Volume: 94, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Disease Progression; Fatigue; Female; Fluorouracil; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Survival Analysis

2006
What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L.
    American journal of hypertension, 2000, Volume: 13, Issue:1 Pt 1

    Topics: Aging; Arteriosclerosis; Carotid Artery Diseases; Disease Progression; Female; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Risk Factors; Sex Characteristics; Vitamins

2000
Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.
    Circulation, 2001, Apr-24, Volume: 103, Issue:16

    Topics: Alleles; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Disease Progression; DNA Mutational Analysis; Female; Follow-Up Studies; Genotype; Homocysteine; Homozygote; Humans; Hyperplasia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk; Stents; Tunica Intima; Ultrasonography, Interventional; Vascular Patency

2001
Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy.
    Metabolism: clinical and experimental, 2001, Volume: 50, Issue:9

    Topics: Adult; Albuminuria; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Erythrocytes; Female; Homocysteine; Humans; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Regression Analysis; Renal Dialysis; S-Adenosylhomocysteine; S-Adenosylmethionine

2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:6

    Topics: Adult; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Regression Analysis

2001
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2002, Volume: 13, Issue:2

    Topics: Biomarkers; Brain; Disease Progression; Double-Blind Method; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamins

2002
Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients.
    Stroke, 2002, Volume: 33, Issue:4

    Topics: Anticoagulants; Aortic Diseases; Arteriosclerosis; Demography; Disease Progression; Echocardiography, Transesophageal; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Remission, Spontaneous; Risk Factors; Stroke; Treatment Outcome

2002

Other Studies

119 other study(ies) available for homocysteine and Disease Exacerbation

ArticleYear
Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease.
    Journal of the neurological sciences, 2022, Mar-15, Volume: 434

    Topics: Cognitive Dysfunction; Disease Progression; Homocysteine; Humans; Parkinson Disease

2022
Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Experimental gerontology, 2023, Volume: 172

    Topics: Alzheimer Disease; Cognition; Cognitive Dysfunction; Disease Progression; Homocysteine; Humans; Neuropsychological Tests; Retrospective Studies

2023
Serum Vitamin B12 and Methylmalonic Acid Status in Migraineurs: A Case-Control Study.
    Headache, 2019, Volume: 59, Issue:9

    Topics: Adolescent; Adult; Anthropometry; Case-Control Studies; Cost of Illness; Disease Progression; Female; Homocysteine; Humans; Male; Methylmalonic Acid; Middle Aged; Migraine Disorders; Nutritional Status; Pain Measurement; Social Class; Vitamin B 12; Young Adult

2019
Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
    Neuroimmunomodulation, 2019, Volume: 26, Issue:5

    Topics: Adult; Aquaporin 4; Autoantibodies; Blood Sedimentation; C-Reactive Protein; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Complement C3; Complement C4; Complement Hemolytic Activity Assay; Disease Progression; Female; Homocysteine; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leukocyte Count; Male; Middle Aged; Neuromyelitis Optica; Severity of Illness Index

2019
Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway.
    Journal of molecular and cellular cardiology, 2020, Volume: 138

    Topics: Animals; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Diet; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Down-Regulation; Foam Cells; HEK293 Cells; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Plaque, Atherosclerotic; Promoter Regions, Genetic; Protein Binding; Signal Transduction; Sp1 Transcription Factor; THP-1 Cells

2020
Association Between Homocysteine and Vascular Calcification Incidence, Prevalence, and Progression in the MESA Cohort.
    Journal of the American Heart Association, 2020, 02-04, Volume: 9, Issue:3

    Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Up-Regulation; Vascular Calcification

2020
Homocysteine induces melanocytes apoptosis via PERK-eIF2α-CHOP pathway in vitiligo.
    Clinical science (London, England : 1979), 2020, 05-29, Volume: 134, Issue:10

    Topics: Adult; Apoptosis; Case-Control Studies; Cell Proliferation; Disease Progression; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Female; Folic Acid; Homocysteine; Humans; Male; Melanins; Melanocytes; Models, Biological; Signal Transduction; Transcription Factor CHOP; Vitiligo

2020
Plasma Homocysteine in Patients with Coronary and Carotid Artery Disease: A Case Control Study.
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2020, Jun-01, Volume: 41, Issue:1

    Topics: Adult; Aged; Angiography; Atherosclerosis; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Coronary Artery Disease; Disease Progression; Endothelium, Vascular; Female; Homocysteine; Humans; Inflammation; Male; Middle Aged; Risk Assessment; Risk Factors

2020
The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease.
    BMC pulmonary medicine, 2020, Sep-07, Volume: 20, Issue:1

    Topics: Acute Disease; Aged; Correlation of Data; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Retrospective Studies

2020
Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
    Kidney & blood pressure research, 2021, Volume: 46, Issue:5

    Topics: Age Factors; Aged; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Incidence; Independent Living; Kidney; Male; Middle Aged; Prognosis; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors

2021
The role of phenylephrine in patients with small deep subcortical infarct and progressive weakness.
    Journal of the neurological sciences, 2017, Jun-15, Volume: 377

    Topics: Aged; Anticoagulants; C-Reactive Protein; Cerebral Infarction; Disease Progression; Female; Hemoglobins; Homocysteine; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Phenylephrine; Pulse Wave Analysis; Regression Analysis; Retrospective Studies; Stroke; Tomography Scanners, X-Ray Computed; Vasoconstrictor Agents

2017
Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Experimental gerontology, 2017, 12-01, Volume: 99

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition; Disease Progression; Female; Folic Acid; Geriatric Assessment; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Male; Mental Status and Dementia Tests; Neuropsychological Tests; Nutrition Assessment; Nutritional Status; Surveys and Questionnaires; Time Factors; Up-Regulation; Vitamin B 12

2017
Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke.
    Medicine, 2017, Volume: 96, Issue:51

    Topics: Age Factors; Body Mass Index; C-Reactive Protein; China; Coronary Disease; Diabetes Complications; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stroke

2017
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia.
    GeroScience, 2018, Volume: 40, Issue:1

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Analysis of Variance; C-Reactive Protein; Case-Control Studies; Cognitive Dysfunction; Dementia; Disability Evaluation; Disease Progression; Female; Geriatric Assessment; Homocysteine; Humans; Inflammation; Italy; Male; Reference Values; Retrospective Studies

2018
Plasma Levels of Homocysteine and the Occurrence and Progression of Rectal Cancer.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Mar-27, Volume: 24

    Topics: Adult; Biomarkers, Tumor; Carcinoembryonic Antigen; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Prognosis; Rectal Neoplasms; ROC Curve

2018
Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
    Clinical biochemistry, 2018, Volume: 56

    Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Dipeptides; Disease Progression; Female; Genetic Association Studies; Glomerulonephritis, IGA; Homocysteine; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Polycystic Kidney, Autosomal Dominant; Polymorphism, Single Nucleotide; Prognosis; Risk; Superoxide Dismutase

2018
Low Plasma Hydrogen Sulfide Is Associated with Impaired Renal Function and Cardiac Dysfunction.
    American journal of nephrology, 2018, Volume: 47, Issue:5

    Topics: Adult; Aged; Biomarkers; Disease Progression; Echocardiography; Female; Glomerular Filtration Rate; Heart Diseases; Homocysteine; Humans; Hydrogen Sulfide; Kidney; Male; Middle Aged; Renal Insufficiency, Chronic

2018
Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis.
    Metabolic brain disease, 2018, Volume: 33, Issue:5

    Topics: Adult; Disability Evaluation; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multiple Sclerosis; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Severity of Illness Index; Tumor Necrosis Factor-alpha

2018
IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study.
    Clinical interventions in aging, 2018, Volume: 13

    Topics: Aged; Aged, 80 and over; Biomarkers; CD40 Ligand; Cerebral Small Vessel Diseases; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Factor 4; Prospective Studies

2018
Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
    Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Infarction; Cerebrovascular Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Female; Homocysteine; Humans; Image Processing, Computer-Assisted; Independent Living; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Risk Factors

2018
Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
    Clinical rheumatology, 2019, Volume: 38, Issue:4

    Topics: Adult; Disease Progression; Female; Homocysteine; Humans; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Peru; Risk Factors; Severity of Illness Index; Social Class

2019
Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.
    Neurobiology of disease, 2019, Volume: 127

    Topics: Animals; Behavior, Animal; Brain; Brain Ischemia; Disease Models, Animal; Disease Progression; Homocysteine; Hyperhomocysteinemia; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Motor Activity; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Severity of Illness Index; Signal Transduction

2019
Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
    Journal of Parkinson's disease, 2019, Volume: 9, Issue:2

    Topics: Aged; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Linear Models; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Prognosis; Prospective Studies; Uric Acid

2019
[Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT)].
    Przeglad lekarski, 2012, Volume: 69, Issue:9

    Topics: Adolescent; Adult; Apolipoproteins B; Atherosclerosis; Biomarkers; Carotid Artery, Common; Carotid Intima-Media Thickness; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Young Adult

2012
Glutathione metabolism in cobalamin deficiency type C (cblC).
    Journal of inherited metabolic disease, 2014, Volume: 37, Issue:1

    Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Carrier Proteins; Case-Control Studies; Child; Child, Preschool; Cysteine; Disease Progression; Female; Glutathione; Homocysteine; Homocystinuria; Humans; Infant; Lymphocytes; Male; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Oxygen; Reactive Oxygen Species; Vitamin B 12; Vitamin B 12 Deficiency

2014
Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia.
    European journal of neurology, 2013, Volume: 20, Issue:8

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Neuropsychological Tests; Perfusion; Risk Factors; Tomography, Emission-Computed, Single-Photon

2013
Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters.
    Acta clinica Croatica, 2013, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Croatia; Diabetes Mellitus, Type 1; Disease Progression; Female; Ferritins; Glycated Hemoglobin; Homocysteine; Humans; Insulin Resistance; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Predictive Value of Tests; Prevalence; Risk Assessment; Risk Factors; Sensitivity and Specificity; Triglycerides; Waist Circumference

2013
Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction.
    Biochimica et biophysica acta, 2013, Volume: 1832, Issue:12

    Topics: Animals; Blood Pressure; Blotting, Western; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Progression; Fibrosis; Glutathione; Homocysteine; Hydrogen Peroxide; Hydrogen Sulfide; Immunoenzyme Techniques; Kidney Diseases; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Signal Transduction; Sulfides; Superoxide Dismutase; Superoxides; Transforming Growth Factor beta1; Ureteral Obstruction

2013
Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.
    Cell biochemistry and biophysics, 2014, Volume: 68, Issue:2

    Topics: BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Disease Progression; DNA Methylation; Epigenesis, Genetic; Female; Homocysteine; Humans; Hyperhomocysteinemia; MCF-7 Cells; Membrane Proteins; Microtubule-Associated Proteins; Proto-Oncogene Proteins; Transcriptome; Tumor Suppressor Proteins; Vitamin B 12

2014
Homocysteine and C-reactive protein associated with progression and prognosis of intracranial branch atheromatous disease.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Aged; C-Reactive Protein; Disease Progression; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Patient Outcome Assessment; Plaque, Atherosclerotic; Prognosis; Retrospective Studies; Risk Factors

2013
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
    Arthritis & rheumatology (Hoboken, N.J.), 2014, Volume: 66, Issue:1

    Topics: Adiponectin; Adult; Age Factors; Apolipoprotein A-I; Atherosclerosis; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Cytokine TWEAK; Diabetes Complications; Diabetes Mellitus; Disease Progression; Female; Homocysteine; Humans; Leptin; Longitudinal Studies; Lupus Erythematosus, Systemic; Middle Aged; Multivariate Analysis; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tumor Necrosis Factors

2014
Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study.
    Neurology, 2014, Mar-04, Volume: 82, Issue:9

    Topics: Age Factors; Aged; Atrophy; Brain; Cerebrovascular Disorders; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Male; Middle Aged; Nerve Fibers, Myelinated; Prospective Studies; Risk Factors; Sex Factors

2014
Homocysteine is linked to macular edema in type 2 diabetes.
    Current eye research, 2014, Volume: 39, Issue:7

    Topics: Adult; Aged; Biomarkers; China; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Homocysteine; Humans; Immunoassay; Incidence; Macular Edema; Male; Middle Aged; Nephelometry and Turbidimetry; Prognosis; Prospective Studies; Retina; Risk Factors; Surveys and Questionnaires

2014
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.
    Atherosclerosis, 2014, Volume: 236, Issue:1

    Topics: Adolescent; Adult; Age Factors; C-Reactive Protein; Carotid Intima-Media Thickness; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Lipids; Male; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Smoking; Young Adult

2014
Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease.
    Journal of nephrology, 2015, Volume: 28, Issue:5

    Topics: Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Cysteine; Diabetes Mellitus, Type 2; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Renal Insufficiency, Chronic; Vitamin B 12

2015
Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    European journal of internal medicine, 2014, Volume: 25, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Disease Progression; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Israel; Linear Models; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Superior Sagittal Sinus; Young Adult

2014
Oral exposure to the anti-pyridoxine compound 1-amino D-proline further perturbs homocysteine metabolism through the transsulfuration pathway in moderately vitamin B₆ deficient rats.
    The Journal of nutritional biochemistry, 2015, Volume: 26, Issue:3

    Topics: Animals; Asymptomatic Diseases; Biomarkers; Cystathionine; Cystathionine gamma-Lyase; Diet; Disease Models, Animal; Disease Progression; Flax; Homocysteine; Hyperhomocysteinemia; Liver; Male; Non-alcoholic Fatty Liver Disease; Proline; Pyridoxal Phosphate; Pyridoxine; Random Allocation; Rats, Sprague-Dawley; Seeds; Vitamin B 6; Vitamin B 6 Deficiency

2015
[Hyperhomocysteinemia--a predictor of inflammatory changes in the liver].
    Likars'ka sprava, 2014, Issue:11

    Topics: Adult; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prognosis; Tumor Necrosis Factor-alpha

2014
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension.
    Journal of the American Society of Hypertension : JASH, 2015, Volume: 9, Issue:3

    Topics: Adult; Aged; Asymptomatic Diseases; Austria; C-Reactive Protein; Carotid Arteries; Carotid Intima-Media Thickness; Carotid Stenosis; Cross-Sectional Studies; Disease Progression; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Statistics as Topic

2015
[Study of serum albumin and BMI as nutritional markers in hemodialysis patients].
    Nutricion hospitalaria, 2014, Oct-03, Volume: 31, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Kaplan-Meier Estimate; Lipids; Male; Malnutrition; Middle Aged; Nutritional Status; Protein-Energy Malnutrition; Renal Dialysis; Renal Insufficiency, Chronic; Sampling Studies; Serum Albumin

2014
Effects of folic acid on dyslipidemia and serum homocysteine in a rat model of cholestasis and hepatic fibrosis.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2015, Volume: 66, Issue:1

    Topics: Animals; Antioxidants; Biomarkers; Cholestasis, Intrahepatic; Cytoprotection; Disease Progression; Dyslipidemias; Folic Acid; Glutathione; Homocysteine; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Rats, Wistar; Time Factors

2015
Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:6

    Topics: Atherosclerosis; Biomarkers; Carotid Stenosis; Disease Progression; Female; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; Risk Factors

2016
Carotid artery intima-media thickness associated with prognosis of intracranial branch atheromatous disease.
    The International journal of neuroscience, 2017, Volume: 127, Issue:4

    Topics: Aged; C-Reactive Protein; Carotid Intima-Media Thickness; Computed Tomography Angiography; Disease Progression; Female; Homocysteine; Humans; Intracranial Arterial Diseases; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Motor Disorders; Plaque, Atherosclerotic; Prognosis; Retrospective Studies

2017
Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
    Neuroscience letters, 2016, 07-28, Volume: 626

    Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Biomarkers; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Progression; Female; Genotype; Homocysteine; Humans; Male; Sensitivity and Specificity

2016
Blood concentration of aminothiols in children with relapse of nephrotic syndrome.
    World journal of pediatrics : WJP, 2016, Volume: 12, Issue:3

    Topics: Adolescent; Biomarkers; Biopsy, Needle; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Dipeptides; Disease Progression; Female; Follow-Up Studies; Glutathione; Homocysteine; Humans; Immunohistochemistry; Male; Nephrotic Syndrome; Recurrence; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sulfhydryl Compounds; Treatment Outcome

2016
Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease.
    Renal failure, 2016, Volume: 38, Issue:8

    Topics: Adult; Biomarkers; C-Reactive Protein; Calcium; Case-Control Studies; Creatinine; Disease Progression; Early Diagnosis; Egypt; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Renal Dialysis; Serum Albumin

2016
Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2017, Volume: 27, Issue:2

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Area Under Curve; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Artery Disease; Cystathionine beta-Synthase; Disease Progression; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Homocysteine; Homozygote; Humans; Kaplan-Meier Estimate; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; ROC Curve; Stroke; Time Factors

2017
Serum homocysteine levels in relation to clinical progression in multiple sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:12

    Topics: Adult; Case-Control Studies; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neurodegenerative Diseases; Neurology; Risk Factors

2008
The relation of plasma homocysteine to radiographic knee osteoarthritis.
    Osteoarthritis and cartilage, 2009, Volume: 17, Issue:6

    Topics: Disease Progression; Epidemiologic Methods; Female; Homocysteine; Humans; Male; Middle Aged; Osteoarthritis, Knee; Predictive Value of Tests; Radiography; Weight-Bearing

2009
Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
    Journal of the neurological sciences, 2009, Aug-15, Volume: 283, Issue:1-2

    Topics: Aged; Aging; Alzheimer Disease; Brain; Cognition Disorders; Disease Progression; Female; Homocysteine; Humans; Hypertension; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated

2009
Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome.
    Respiration; international review of thoracic diseases, 2010, Volume: 79, Issue:1

    Topics: Adult; Aged; Disease Progression; Female; Heart Diseases; Homocysteine; Humans; Male; Middle Aged; Respiratory Function Tests; Sleep Apnea, Obstructive; Ultrasonography

2010
C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome.
    Fertility and sterility, 2010, Volume: 94, Issue:1

    Topics: Adult; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Heart Rate; Homocysteine; Humans; Polycystic Ovary Syndrome; Prospective Studies; Young Adult

2010
[Different patterns of homocysteine in patients with peripheral arterial disease].
    Medicina clinica, 2010, Apr-10, Volume: 134, Issue:10

    Topics: Analysis of Variance; C-Reactive Protein; Disease Progression; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Inflammation; Nephelometry and Turbidimetry; Peripheral Vascular Diseases; Risk Factors

2010
Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci.
    Carcinogenesis, 2009, Volume: 30, Issue:9

    Topics: Animals; Cell Proliferation; Colorectal Neoplasms; Dietary Supplements; Disease Progression; Folic Acid; Homocysteine; Liver; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley

2009
A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine.
    Dementia and geriatric cognitive disorders, 2009, Volume: 28, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Cohort Studies; Creatinine; Disease Progression; Female; Homocysteine; Humans; Male; Neuropsychological Tests; Prospective Studies; Risk Assessment; Socioeconomic Factors; Sweden; Thyrotropin

2009
Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers.
    Thrombosis and haemostasis, 2010, Volume: 103, Issue:5

    Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Creatinine; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Neopterin; Vitamin B 12

2010
Thrombophilic risk factors and peripheral arterial disease severity.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:1

    Topics: Aged; Constriction, Pathologic; Disease Progression; DNA Mutational Analysis; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Ischemia; Lupus Coagulation Inhibitor; Male; Mutation; Peripheral Arterial Disease; Polymorphism, Genetic; Prothrombin; Risk Factors; Thrombophilia

2010
Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
    The American journal of cardiology, 2010, May-01, Volume: 105, Issue:9

    Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Incidence; Leukocyte Count; Lipoproteins; Male; Middle Aged; Platelet Count; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; United States

2010
Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.
    Journal of hepatology, 2010, Volume: 53, Issue:3

    Topics: Adult; Aged; Alcoholism; Aminobutyrates; Biomarkers; Case-Control Studies; Cystathionine; Disease Progression; Female; Homocysteine; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Male; Methionine; Middle Aged; Sulfur; Young Adult

2010
Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.
    Nature reviews. Endocrinology, 2010, Volume: 6, Issue:9

    Topics: Cardiovascular Diseases; Diabetic Nephropathies; Disease Progression; Down-Regulation; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Vitamin B 12; Vitamin B 6; Vitamins

2010
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010, Volume: 19, Issue:11

    Topics: Aged; Biomarkers, Tumor; Disease Progression; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Vitamin B 12

2010
Recessive spastic paraparesis associated with complex I deficiency due to MTHFR mutations.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:1

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Disease Progression; Electron Transport Complex I; Genes, Recessive; Homocysteine; Homozygote; Humans; Mutation, Missense; Paraparesis, Spastic; Siblings; Young Adult

2012
Inhibition of hepatic glycogen synthesis by hyperhomocysteinemia mediated by TRB3.
    The American journal of pathology, 2011, Volume: 178, Issue:4

    Topics: Animals; Cell Cycle Proteins; Disease Progression; Glycogen; Homocysteine; Humans; Hyperhomocysteinemia; Indoles; Insulin Resistance; Liver Glycogen; Methionine; Mice; Phosphorylation; PPAR gamma; Protein Serine-Threonine Kinases; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering

2011
Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction. Homocysteine and congestive heart failure.
    International heart journal, 2011, Volume: 52, Issue:4

    Topics: Biomarkers; Chromatography, High Pressure Liquid; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Homocysteine; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Retrospective Studies

2011
Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study.
    Immunobiology, 2011, Volume: 216, Issue:12

    Topics: Adult; Antibodies, Antiphospholipid; Apolipoproteins; Arthritis, Rheumatoid; Atherosclerosis; beta 2-Glycoprotein I; Carotid Intima-Media Thickness; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Immunoglobulin A; Middle Aged; Plaque, Atherosclerotic; Prognosis; Risk Factors; Ultrasonography

2011
Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study.
    International heart journal, 2011, Volume: 52, Issue:5

    Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Analysis

2011
Cystatin C levels are associated with the prognosis of systolic heart failure patients.
    Archives of cardiovascular diseases, 2011, Volume: 104, Issue:11

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Agents; China; Cystatin C; Disease Progression; Female; Heart Failure, Systolic; Heart Transplantation; Homocysteine; Hospitals, University; Humans; Inflammation Mediators; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation

2011
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Choline; Decitabine; Diet; Disease Progression; DNA Methylation; Folic Acid; Homocysteine; Humans; Male; Methionine; Mice; Mice, Nude; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin B 6

2012
Nɛ-homocysteinyl-lysine isopeptide is associated with progression of peripheral artery disease in patients treated with folic acid.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2012, Volume: 43, Issue:5

    Topics: Aged; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolism; Middle Aged; Oxidative Stress; Peptides; Peripheral Arterial Disease; Proteins; Vitamin B Complex

2012
[Hyperhomocysteinemia and plasma acute-phase proteins in patients with type 2 diabetes mellitus and severe course of atherosclerosis after vascular operations].
    Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2011, Volume: 17, Issue:4

    Topics: Atherosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Disease Progression; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Middle Aged; Postoperative Complications; Risk Assessment; Severity of Illness Index; Statistics as Topic; Vascular Surgical Procedures

2011
Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Atherosclerosis, 2012, Volume: 223, Issue:2

    Topics: Adiponectin; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Biomarkers; Brachiocephalic Trunk; Cholesterol, Dietary; Diet, Atherogenic; Diet, Carbohydrate-Restricted; Diet, High-Fat; Dietary Proteins; Disease Models, Animal; Disease Progression; Female; Homocysteine; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Risk Factors; Rupture, Spontaneous; Triglycerides

2012
Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2013, Volume: 9, Issue:3

    Topics: Aged; Aging; Atherosclerosis; Atrophy; Biomarkers; Cerebral Infarction; Cerebral Ventricles; Cognition Disorders; Disease Progression; Executive Function; Female; Homocysteine; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Risk Factors

2013
[Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus].
    Medicina clinica, 2013, Nov-02, Volume: 141, Issue:9

    Topics: Age Factors; Aged; Alcohol Drinking; Cardiovascular Diseases; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Hypesthesia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Overweight; Physical Examination; Risk Factors; Severity of Illness Index; Smoking; Vitamin B 12

2013
Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients.
    Nephron, 2002, Volume: 92, Issue:1

    Topics: Adolescent; Adult; Age Factors; Disease Progression; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Single Nucleotide; Renal Dialysis; Risk Factors

2002
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.
    Journal of the American College of Cardiology, 2002, Oct-16, Volume: 40, Issue:8

    Topics: Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment; ROC Curve

2002
Serum folate and homocysteine levels in head and neck squamous cell carcinoma.
    Cancer, 2002, Nov-15, Volume: 95, Issue:10

    Topics: Carcinoma, Squamous Cell; Disease Progression; Folic Acid; Head and Neck Neoplasms; Homocysteine; Humans; Hyperhomocysteinemia; Neopterin; Prognosis; Risk Factors

2002
Plasma homocysteine level and the course of ischemic stroke.
    Acta neurobiologiae experimentalis, 2003, Volume: 63, Issue:2

    Topics: Aged; Brain Ischemia; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Risk Factors; Stroke

2003
[Homocysteine and progression of carotid atherosclerosis in patients with coronary disease].
    Medicina clinica, 2003, Nov-01, Volume: 121, Issue:15

    Topics: Arteriosclerosis; Carotid Artery Diseases; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged

2003
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:2

    Topics: Adult; Biomarkers; Central Nervous System Agents; Disease Progression; Drug Interactions; Female; Homocysteine; Humans; Huntingtin Protein; Huntington Disease; Hyperhomocysteinemia; Male; Metabolic Clearance Rate; Middle Aged; Mutation; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins

2004
Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.
    Archives of neurology, 2004, Volume: 61, Issue:5

    Topics: Aged; Alzheimer Disease; Apolipoproteins E; Biomarkers; Brain; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Prospective Studies; Radiography; Risk Factors; tau Proteins

2004
Homocysteine and progression of coronary artery disease.
    Kardiologia polska, 2004, Volume: 60, Issue:3

    Topics: Adult; Blood Glucose; Coronary Artery Disease; Disease Progression; Folic Acid; Homocysteine; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Obesity; Research Design; Risk Factors; Smoking; Vitamin B 12

2004
Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
    International journal of geriatric psychiatry, 2004, Volume: 19, Issue:7

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Disease Progression; Female; Homocysteine; Humans; Male; Regression Analysis; Statistics, Nonparametric; Time Factors

2004
Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:11

    Topics: Coronary Disease; Disease Progression; Female; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Time Factors

2004
Plasma homocysteine and insulin in diabetic nephropathy: relationship to body mass index.
    Renal failure, 2004, Volume: 26, Issue:6

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homocysteine; Humans; Insulin; Male; Middle Aged; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index

2004
Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
    Neurology, 2005, Apr-26, Volume: 64, Issue:8

    Topics: Adult; Anticoagulants; Betaine; Cognition Disorders; Confusion; Disease Progression; Drug Therapy, Combination; Folic Acid; Frontal Lobe; Homocysteine; Humans; Hyperhomocysteinemia; Leukoaraiosis; Magnetic Resonance Imaging; Male; Methylmalonic Acid; Remission Induction; Seizures; Treatment Outcome; Vitamin B 12; Vitamin B 6

2005
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.
    Stroke, 2005, Volume: 36, Issue:6

    Topics: Aged; Brain; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Magnetic Resonance Imaging; Male; Middle Aged; New York; Risk Factors; Social Class; Stroke; Vitamin B 12 Deficiency

2005
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
    American heart journal, 2005, Volume: 149, Issue:5

    Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer

2005
[Significance of homocysteines in the development of acute myocardial infarction].
    Georgian medical news, 2005, Issue:121

    Topics: Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Homocysteine; Humans; Myocardial Infarction; Risk Factors; Severity of Illness Index

2005
Plasma homocysteine predicts progression of atherosclerosis.
    Atherosclerosis, 2005, Volume: 181, Issue:1

    Topics: Adult; Aged; C-Reactive Protein; Calcinosis; Cohort Studies; Coronary Artery Disease; Coronary Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, X-Ray Computed

2005
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Atherosclerosis, 2006, Volume: 184, Issue:2

    Topics: Adult; Aged; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Retrospective Studies; Risk Factors; Smoking

2006
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:8

    Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular System; Cohort Studies; Dialysis; Disease Progression; Enzyme Inhibitors; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Middle Aged; Models, Statistical; Models, Theoretical; Proportional Hazards Models; Proteinuria; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome

2005
Smoking, homocysteine and degree of arteriolar retinopathy.
    Atherosclerosis, 2005, Volume: 183, Issue:1

    Topics: Adult; Arterioles; China; Cross-Sectional Studies; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Middle Aged; Odds Ratio; Ophthalmoscopy; Prevalence; Retinal Diseases; Retinal Vessels; Risk Factors; Sampling Studies; Severity of Illness Index; Smoking

2005
Clinical course in Parkinson's disease with elevated homocysteine.
    Parkinsonism & related disorders, 2006, Volume: 12, Issue:2

    Topics: Affect; Aged; Aged, 80 and over; Biomarkers; Cognition; Cohort Studies; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Risk Factors; Vitamin B Complex; Vitamins

2006
[Study of serum levels of homocystein, lipids and their peroxidation products in patients with coronary heart disease].
    Klinicheskaia meditsina, 2005, Volume: 83, Issue:11

    Topics: Adult; Biomarkers; Disease Progression; Female; Homocysteine; Humans; Lipid Peroxidation; Lipids; Male; Middle Aged; Myocardial Ischemia; Prognosis; Risk Factors; Severity of Illness Index

2005
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    International journal of geriatric psychiatry, 2006, Volume: 21, Issue:6

    Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cognition Disorders; Dementia; Disease Progression; Educational Status; Female; Homocysteine; Humans; Male; Memory Disorders; Neuropsychological Tests; Prognosis; Psychiatric Status Rating Scales; Risk Factors

2006
Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease.
    Neurology, 2006, May-23, Volume: 66, Issue:10

    Topics: Adult; Atrophy; Brain; CADASIL; Cognition Disorders; Comorbidity; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Risk Factors; Smoking

2006
Risk factors for progression of peripheral arterial disease in large and small vessels.
    Circulation, 2006, Jun-06, Volume: 113, Issue:22

    Topics: Aged; Ankle; Brachial Artery; C-Reactive Protein; Cholesterol, HDL; Diabetes Mellitus; Diabetic Angiopathies; Disease Progression; Female; Homocysteine; Humans; Inflammation; Lipoprotein(a); Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Predictive Value of Tests; Regression Analysis; Risk Factors; Serum Amyloid A Protein; Smoking; Toes

2006
[Peculiarities of atherosclerotic injury of carotid arteries in patients with coronary artery disease with hyperhomocysteinemia].
    Kardiologiia, 2006, Volume: 46, Issue:5

    Topics: Adult; Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Coronary Disease; Disease Progression; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Severity of Illness Index; Ultrasonography

2006
[Markers predicting progression of disease in PAD: Which of them are both relevant to clinical practice and economically justifiable?].
    Hamostaseologie, 2006, Volume: 26, Issue:3

    Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cost of Illness; Disease Progression; Germany; Homocysteine; Humans; Multivariate Analysis; Peripheral Vascular Diseases; Risk Factors

2006
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:1

    Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Disease Progression; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Polymorphism, Single Nucleotide; Time Factors

2007
Clinical and biochemical studies on Chinese patients with methylmalonic aciduria.
    Journal of child neurology, 2006, Volume: 21, Issue:12

    Topics: Adolescent; Adult; Age of Onset; Amino Acid Metabolism, Inborn Errors; Biomarkers; Child; Child, Preschool; China; Chronic Disease; Comorbidity; Disease Progression; Female; Homocysteine; Homocystinuria; Humans; Infant; Infant, Newborn; Male; Methylmalonic Acid; Methylmalonyl-CoA Mutase; Predictive Value of Tests; Prognosis; Survival Rate

2006
[Neurological syndromes associated with homocystein dismetabolism].
    Klinicheskaia meditsina, 2006, Volume: 84, Issue:12

    Topics: Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Leukoencephalitis, Acute Hemorrhagic; Magnetic Resonance Imaging; Male; Middle Aged; Polyneuropathies; Prognosis; Risk Factors; Stroke

2006
Relationship of vascular risk to the progression of Alzheimer disease.
    Neurology, 2007, Mar-27, Volume: 68, Issue:13

    Topics: Alzheimer Disease; Apolipoproteins E; Cerebral Arteries; Cerebrovascular Disorders; Cholesterol; Disease Progression; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperlipidemias; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors

2007
Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack.
    Circulation, 2007, Aug-21, Volume: 116, Issue:8

    Topics: Aged; Aorta, Thoracic; Atherosclerosis; Disease Progression; Disease-Free Survival; Echocardiography, Transesophageal; Female; Follow-Up Studies; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Prevalence; Recurrence; Risk Factors; Stroke

2007
[Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:6

    Topics: Adult; Annexins; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Disease Progression; Endothelium, Vascular; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Risk Factors; Tunica Intima; Ultrasonography, Doppler

2007
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:2

    Topics: Adult; Age Factors; Aged; Disease Progression; Female; Hepatitis C, Chronic; Homocysteine; Humans; Liver Cirrhosis; Liver Transplantation; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Recurrence

2008
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:10

    Topics: Adult; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Ultrasonography

2007
Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis.
    Journal of neurology, 2008, Volume: 255, Issue:1

    Topics: Age of Onset; Brain; Cognition Disorders; Disability Evaluation; Disease Progression; Folic Acid; Homocysteine; Hyperhomocysteinemia; Multiple Sclerosis; Multivariate Analysis; Neuropsychological Tests; Predictive Value of Tests; Up-Regulation; Vitamin B 12 Deficiency

2008
Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:12

    Topics: Aged; alpha-Tocopherol; Ascorbic Acid; Biomarkers; Case-Control Studies; Chronic Disease; Cysteine; Dipeptides; Disease Progression; Female; Glutathione; Heart Failure; Homocysteine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Oxidation-Reduction; Oxidative Stress; Research Design; Sulfhydryl Compounds

2007
Changes in plasma levels of homocysteine in patients with acute pancreatitis.
    JOP : Journal of the pancreas, 2008, May-08, Volume: 9, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Blood Urea Nitrogen; C-Reactive Protein; Case-Control Studies; Creatinine; Disease Progression; Female; Follow-Up Studies; Homocysteine; Humans; Leukocyte Count; Lipids; Male; Middle Aged; Pancreatitis; Time Factors

2008
From microalbuminuria to hyperhomocysteinemia.
    Kidney international, 1998, Volume: 54, Issue:1

    Topics: Albuminuria; Diabetic Nephropathies; Disease Progression; Homocysteine; Humans

1998
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
    Archives of neurology, 1998, Volume: 55, Issue:11

    Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Case-Control Studies; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Memory Disorders; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors; Vascular Diseases; Vitamin B 12

1998
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
    Journal of vascular surgery, 1999, Volume: 29, Issue:1

    Topics: Aged; Analysis of Variance; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Mortality; Multivariate Analysis; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Single-Blind Method

1999
The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
    Nephron, 1999, Volume: 82, Issue:4

    Topics: Adult; Aged; Blood Pressure; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prospective Studies

1999
The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service.
    Journal of vascular surgery, 1999, Volume: 30, Issue:3

    Topics: Adult; Age Factors; Age of Onset; Amputation, Surgical; Arterial Occlusive Diseases; Blood Coagulation Disorders; Blood Pressure; Confidence Intervals; Diabetes Complications; Disease Progression; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Hypertension; Incidence; Ischemia; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Postoperative Complications; Prevalence; Prospective Studies; Reoperation; Smoking; Treatment Outcome

1999
Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia.
    Annals of the New York Academy of Sciences, 2000, Volume: 903

    Topics: Aged; Alzheimer Disease; Blood Pressure; Brain; Dementia, Vascular; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Male; Mental Status Schedule; Retrospective Studies; Tomography, X-Ray Computed

2000
Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.
    Thrombosis research, 2001, Sep-30, Volume: 103 Suppl 1

    Topics: Adult; Age of Onset; Analysis of Variance; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction

2001
Serum folate and homocysteine levels in head and neck squamous cell carcinoma.
    Cancer, 2002, Feb-15, Volume: 94, Issue:4

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Disease Progression; Female; Folic Acid; Head and Neck Neoplasms; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking

2002
Multiple panel of biomarkers for TIA/stroke evaluation.
    Stroke, 2002, Volume: 33, Issue:5

    Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Autoantibodies; Biomarkers; Diagnosis, Differential; Disease Progression; Female; Glutamic Acid; Glycine; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Neuroprotective Agents; Predictive Value of Tests; Receptors, N-Methyl-D-Aspartate; Stroke; Tomography, X-Ray Computed

2002